Integral Ad Science (NASDAQ:IAS) Given New $12.00 Price Target at Barclays

Integral Ad Science (NASDAQ:IAS) had its price objective lowered by Barclays from $16.00 to $12.00 in a report published on Monday morning, Benzinga reports. Barclays currently has an equal weight rating on the stock.

Other analysts have also issued research reports about the company. Raymond James lowered Integral Ad Science from a strong-buy rating to an outperform rating and dropped their price objective for the company from $20.00 to $16.00 in a research note on Wednesday, February 28th. Bank of America initiated coverage on Integral Ad Science in a research note on Thursday, January 11th. They set a buy rating and a $19.00 price objective for the company. Oppenheimer dropped their price target on Integral Ad Science from $25.00 to $20.00 and set an outperform rating for the company in a research note on Wednesday, February 28th. BMO Capital Markets dropped their price target on Integral Ad Science from $18.00 to $16.00 and set an outperform rating for the company in a research note on Wednesday, February 28th. Finally, Truist Financial dropped their price target on Integral Ad Science from $26.00 to $17.00 and set a buy rating for the company in a research note on Wednesday, February 28th. Two analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of Moderate Buy and a consensus target price of $17.96.

Integral Ad Science Stock Down 3.3 %

Shares of NASDAQ IAS opened at $9.54 on Monday. Integral Ad Science has a one year low of $9.10 and a one year high of $20.88. The company has a debt-to-equity ratio of 0.17, a current ratio of 3.21 and a quick ratio of 3.21. The firm’s 50 day simple moving average is $11.82 and its two-hundred day simple moving average is $13.11. The stock has a market capitalization of $1.52 billion, a P/E ratio of 238.56, a PEG ratio of 1.71 and a beta of 1.60.

Integral Ad Science (NASDAQ:IAS) last issued its quarterly earnings results on Tuesday, February 27th. The company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03. The business had revenue of $134.30 million for the quarter, compared to analysts’ expectations of $131.27 million. Integral Ad Science had a net margin of 1.53% and a return on equity of 0.83%. The business’s quarterly revenue was up 14.4% on a year-over-year basis. During the same period last year, the business earned $0.07 earnings per share. As a group, analysts expect that Integral Ad Science will post 0.16 EPS for the current fiscal year.

Insider Activity

In other news, CEO Lisa Utzschneider sold 13,113 shares of the firm’s stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $15.79, for a total transaction of $207,054.27. Following the completion of the transaction, the chief executive officer now directly owns 148,657 shares in the company, valued at $2,347,294.03. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CAO Alexis Gil II sold 3,177 shares of Integral Ad Science stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $10.24, for a total value of $32,532.48. Following the completion of the sale, the chief accounting officer now directly owns 120,195 shares in the company, valued at approximately $1,230,796.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Lisa Utzschneider sold 13,113 shares of Integral Ad Science stock in a transaction dated Tuesday, February 6th. The stock was sold at an average price of $15.79, for a total value of $207,054.27. Following the completion of the sale, the chief executive officer now owns 148,657 shares of the company’s stock, valued at $2,347,294.03. The disclosure for this sale can be found here. Insiders sold 80,195 shares of company stock worth $876,562 over the last three months. 2.00% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Integral Ad Science

Large investors have recently bought and sold shares of the business. Ameritas Investment Partners Inc. increased its holdings in Integral Ad Science by 92.1% in the 1st quarter. Ameritas Investment Partners Inc. now owns 2,499 shares of the company’s stock worth $34,000 after buying an additional 1,198 shares in the last quarter. Skandinaviska Enskilda Banken AB publ bought a new stake in Integral Ad Science in the 3rd quarter worth about $58,000. Tower Research Capital LLC TRC increased its holdings in Integral Ad Science by 493.4% in the 3rd quarter. Tower Research Capital LLC TRC now owns 8,581 shares of the company’s stock worth $62,000 after buying an additional 7,135 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new stake in shares of Integral Ad Science during the 3rd quarter valued at about $62,000. Finally, Amalgamated Bank grew its stake in shares of Integral Ad Science by 19.9% during the 3rd quarter. Amalgamated Bank now owns 6,951 shares of the company’s stock valued at $83,000 after purchasing an additional 1,156 shares during the period. 95.78% of the stock is currently owned by institutional investors.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.